Location History:
- Mölndal, SE (2013)
- Molndal, SE (2018)
Company Filing History:
Years Active: 2013-2018
Title: The Innovative Contributions of Carl Anders Hogner
Introduction
Carl Anders Hogner, hailing from Molndal, Sweden, is a recognized inventor with a significant impact in the field of pharmaceutical sciences. With two patents to his name, Hogner is making strides in the development of novel compounds that have potential therapeutic applications. His work is a testament to his commitment to advancing medical treatments.
Latest Patents
Hogner's latest patents include innovations that focus on improving vascular function and addressing melanin-concentrating hormone-related conditions. The first patent involves "Benzoxazinone amides as mineralocorticoid receptor modulators," which disclose certain derivatives of benzoxazinone amides that may reduce oxidative stress in endothelium. This development could significantly enhance vascular health through its potential therapeutic use and pharmaceutical compositions.
The second patent, focusing on "(3-(4-(aminomethyl)phenoxy or phenylthio)azetidin-1-yl)(5-phenyl-1,3,4-oxadiazol-2-yl)methanone compounds," describes azetidinyl compounds intended for the treatment or prophylaxis of diseases related to melanin-concentrating hormone. This innovation opens new avenues for targeted therapies in complex medical conditions.
Career Highlights
Carl Anders Hogner currently works at AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to collaborate with other professionals and contribute to cutting-edge research that yields impactful health solutions.
Collaborations
Within the esteemed environment of AstraZeneca, Hogner has had the opportunity to work alongside notable colleagues such as Gavin O'Mahony and Michael Kossenjans. These collaborations foster a culture of innovation, leading to the development of groundbreaking pharmaceutical products.
Conclusion
Carl Anders Hogner is a prominent figure in the realm of innovation and pharmaceutical development. Through his patents and collaborative efforts at AstraZeneca, he continues to enhance our understanding of medicinal chemistry and develop treatments that may improve patients' lives. His contributions are essential in the ongoing pursuit of medical advancements, showcasing the vital role of inventors in healthcare innovation.